Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
U.S.: The Food and Drug Administration (FDA) is the primary regulatory body, ensuring the safety and efficacy of incretin mimetics like Exenatide, Liraglutide, Dulaglutide, and Semaglutide
Beyond BMI criteria, ideal candidates are patients who have attempted lifestyle modifications (diet, exercise) without achieving adequate or sustained weight loss
Additional information Communicated by Massimo Federici, M.D Publishers note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Another 35 percent were classified as overweight, with a BMI of 25 to 30
US$ 22.70
US$ 27.34
US$ 21.44
US$ 20.89
US$ 25.99
US$ 25.30
US$ 26.31
US$ 28.48
US$ 27.20
US$ 26.22
US$ 22.35
